Vertex and Ribometrix collaborate on discovery and development of RNA-targeted therapeutics Oct. 1, 2019
Idera initiates ILLUMINATE-206 study of tilsotolimod in combination with nivolumab and ipilimumab Oct. 1, 2019
Biallelic ZNF142-null mutations as new gene biomarkers in patients with generalized dystonia Oct. 1, 2019
RSS